Latest news with #Divi'sLaboratories
Mint
3 days ago
- Business
- Mint
Top three stocks to buy today—recommended by Ankush Bajaj for 10 July
Indian stock market benchmarks ended in the red on Wednesday, July 9, as uncertainty over US tariffs kept investors away from riskier equities. Caution ahead of the Q1FY26 earnings season also added pressure on the market. The Sensex snapped its three-day winning streak to close at 83,536.08, down 176 points, or 0.21 per cent. The Nifty 50 settled with a loss of 46 points, or 0.18 per cent, at 25, 3 Stocks Recommended by Ankush Bajaj for 10 July Why it's recommended:Divi's Laboratories is showing strong upward momentum, supported by a robust technical setup. The stock is trading well above all its key moving averages, confirming a sustained bullish trend. Thedaily RSI stands at 71, reflecting strong momentum while still sustaining in the bullish territory without being excessively overbought. The overall structure points to continued upward movement as the stock maintains higher lows and strong buying interest on dips. Key metrics: Support (stop loss): ₹6,910 Pattern: Momentum-driven breakout continuation above major averages RSI: 71 (indicating strong bullish momentum) Technical analysis:The stock remains in a powerful uptrend and is holding above its key short- and long-term moving averages, reinforcing trend strength. With consistent demand and positive price structure, the next upside move toward ₹7,125– ₹7,140 looks well supported. Traders are advised to maintain positions as long as the price holds above the ₹6,910 support level. Risk factors:Any close below ₹6,910 would weaken the current setup. Watch for signs of fatigue or low-volume rallies, which may hint at short-term exhaustion. Buy at: ₹6,983 Target price: ₹7,125– ₹7,140 Stop loss: ₹6,910 Buy: Indian Energy Exchange (IEX) — Current Price: ₹208 Why it's recommended:IEX has recently broken out of a triangle pattern on the lower timeframes, suggesting a renewed push higher after a phase of consolidation. Thedaily RSI is at 69, just shy of overbought levels, confirming strong momentum. This combination of breakout and positive momentum increases the probability of sustained gains in the near term. Key metrics: Support (stop loss): ₹202, Pattern: Triangle breakout on intraday charts RSI: 69 (bullish zone) Technical analysis:The breakout from the triangle pattern is supported by improving volumes and strong follow-through. The price action suggests the potential for a move toward ₹220– ₹222 in the short term. As long as the stock sustains above ₹202, the bullish momentum is expected to continue. Risk factors:A fall below ₹202 may invalidate the breakout structure. Traders should also monitor whether the breakout is supported by rising volumes. Buy at: ₹208 Target price: ₹220– ₹222 Stop loss: ₹202 Buy: IIFL Finance — Current Price: ₹508.55 Why it's recommended:IIFL Finance has shown a sharp upward move afterbreaking out of a rectangle pattern on the 15-minute chart, indicating a fresh bullish phase. Thedaily RSI is elevated at 72, which confirms strong buying interest and a possible continuation of the trend. The overall structure supports a short-term rally with minor dips being actively bought into. Key metrics: Support (stop loss): ₹498 Pattern: Rectangle breakout on 15-min chart RSI: 72 (strong bullish momentum) Technical analysis: The breakout has occurred with clean price action, and follow-through buying suggests higher levels are likely. With the bullish setup confirmed and momentum indicators supporting the move, the stock may advance toward ₹530– ₹532 in the short term. A close below ₹498 would weaken the trend. Risk factors: Watch for volume tapering or failure to hold above ₹505 levels, which may invite quick profit-taking. Buy at: ₹508.55 Target price: ₹530– ₹532 Stop loss: ₹498 Market Wrap On Wednesday, the Indian stock market traded within a narrow range, reflecting a lack of broad conviction but evident interest in select defensives. While overall momentum remained muted, a defensive tilt helped the indices stay afloat, highlighting investors' cautious optimism amid sectoral churn. The Nifty 50 managed to hold its ground, edging up just 46.40 points or 0.18% to settle at 25,476.10, while the BSE Sensex added 176.43 points or 0.21% to end at 83,536.08. Bank Nifty saw limited movement, gaining 42.75 points or 0.07% to close at 57,213.55, with buying concentrated in a few heavyweight financial stocks. Sectoral activity showed a mix of pressure and resilience. Cyclical sectors took a backseat, with Realty down 1.49%, Metal slipping 1.40%, and Oil & Gas losing 1.25% as traders booked profits. On the other hand, defensive sectors provided some cushion — FMCG led the pack with a gain of 0.80%, Auto edged up 0.38%, and Pharma posted a marginal rise of 0.19%, indicating a tilt toward stability amid uncertainty. In the stock-specific action, Shriram Finance led the gainers with a 1.81% jump on strong institutional interest. Bajaj Finance moved up by 1.40%, while Hindustan Unilever advanced 1.28%, driven by consistent demand for high-quality names. Conversely, some recent outperformers came under selling pressure —HCL Tech dropped 2.00%, Tata Steel declined 1.83%, and Hindalco slipped 1.70%, pointing to sector-specific profit booking. Nifty Technical Analysis Daily & Hourly The Nifty ended Wednesday's session on a subdued note, slipping 46.40 points or 0.18% to close at 25,476.10. A Doji candlestick was formed on the daily chart for the second consecutive day, signaling continued indecision among traders following the recent uptrend. Despite the minor loss, the broader bullish structure remains intact, although momentum appears to be slowing. From a technical perspective, the index is still trading comfortably above its key moving averages, with the 20-day simple moving average placed at 25,220 and the 40-day exponential moving average at 24,994. This setup indicates that the medium-term trend is still positive. However, momentum indicators are beginning to show signs of fatigue. The Relative Strength Index (RSI) on the daily chart has eased to 60, reflecting weakening upward momentum, while the MACD has slipped slightly below its signal line, reading 200 versus 203. This crossover suggests that bullish momentum is beginning to wane, increasing the risk of a pause or consolidation in the near term. The intraday picture presents a similar story of softening strength. On the hourly chart, Nifty is hovering just above its 20-hour moving average of 25,469 and the 40-hour EMA of 25,467. The hourly RSI has dropped to 47, close to neutral territory, and the MACD, while still in positive territory at 13.42, remains below its signal line at 13.82. These indicators point to declining short-term momentum and suggest a potential for sideways price action or minor pullbacks. In the derivatives space, the options data paints a distinctly bearish picture. Total Call open interest now stands at 18.16 crore, significantly higher than the 12.80 crore in Puts, resulting in a net difference of –5.36 crore. This clearly reflects a negative bias in positioning. Additionally, the change in open interest reinforces this view, with Calls seeing an increase of 4.39 crore contracts while Puts witnessed a marginal decline of 7.62 lakh contracts. The net shift of –4.47 crore contracts confirms fresh Call writing and a lack of strong Put support, suggesting that traders are bracing for continued resistance near current levels. Strike-wise data shows that the 25,500 level has become a key battleground. It holds the highest Call open interest as well as the most active Call additions, making it a firm resistance zone. Interestingly, it also houses the highest Put open interest, indicating a tug-of-war between bulls and bears at this strike. A decisive move above or below this level may trigger a directional breakout. On the volatility front, India VIX dipped by 2.09% to 11.94, suggesting that market participants remain largely composed and are not aggressively pricing in downside risk. Overall market breadth appeared neutral to mildly negative, in line with the Doji formation and consolidative tone. In summary, while the Nifty's medium-term trend remains positive and supported by moving averages, the short-term indicators suggest a slowing pace and a possible consolidation phase. The repeated Doji formations, soft intraday indicators, and bearish derivatives data highlight growing caution. Unless the index breaks above 25,550–25,600 decisively, the market may continue to trade within a range of 25,200 to 25,600. Traders are advised to remain cautious and consider long positions only on dips toward the 25,200–25,250 zone with strict stops below 25,150. A breakout above 25,600 would be needed to confirm renewed directional momentum. Ankush Bajaj is a Sebi-registered research analyst. His registration number is INH000010441. Investments in securities are subject to market risks. Read all the related documents carefully before investing. Registration granted by Sebi and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors. Disclaimer: The views and recommendations given in this article are those of individual analysts. These do not represent the views of Mint. We advise investors to check with certified experts before making any investment decisions.
Business Upturn
5 days ago
- Business
- Business Upturn
Divi's Laboratories share hits new 52-week high as HSBC upgrades to ‘Buy', raises target price to Rs 7,900
By Aman Shukla Published on July 8, 2025, 09:26 IST Divi's Laboratories shares surged to a new 52-week high of ₹7,071.50 on July 8 after HSBC upgraded the stock to Buy and sharply raised its target price to ₹7,900 from ₹5,020. HSBC's bullish stance is driven by a strong medium-term outlook, with significant revenue potential from high-growth segments like tirzepatide, other peptides, and contrast media. The brokerage estimates around USD 450 million in peptide revenue and USD 260 million from contrast media by 2030. Citing Divi's leadership in custom synthesis and complex API manufacturing, HSBC projects a 23% CAGR in earnings per share for FY25–28. The firm sees Divi's benefiting from the global trend of outsourcing complex molecules, boosting profitability and margins over time. The stock opened at ₹7,002 and hit an intraday low of ₹6,972.50 before climbing to its fresh peak. Divi's Laboratories' previous 52-week low stood at ₹4,395.30. Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
India.com
03-07-2025
- Business
- India.com
Meet multi-millionaire industrialist, who saw 78 percent rise in wealth, a close competitor of Mukesh Ambani, Gautam Adani, his name is...
Satyanarayan Nuwal New Delhi: India's top 20 industrialists have witnessed a major profit in the first half of 2025. At a time when the market was in a volatile state, they achieved an average return of 15.6 percent, while the Sensex delivered a return of 7.11 percent. Satyanarayan Nuwal, Co-founder and Chairman of Solar Industries, saw the highest rise in wealth, with a massive surge of 78.4 percent. His company manufactures explosives, detonators, drones, and ammunition. It is important to note that out of the top 20, 14 industrialists experienced a wealth increase of at least 8.5 percent. Only 6 saw their wealth decline, ranging between 4 percent and 25 percent. During this time, Ravi Jaipuria, Chairman of RJ Corp, witnessed a 24.6 percent drop in his wealth. Meet Satyanarayan Nuwal: Satyanarayan Nuwal, 72, began his Solar Industries India in 1995 Solar Industries India started to trade in industrial explosives then started manufacturing them. The biggest chunk of its annual revenue is from exports, followed by housing and infrastructure, state-owned coal companies and the defense sector. Satyanarayan Nuwal is the son of a government employee Nuwal set up his first business, an ink manufacturing unit in 1970 at age 18. It has 25 manufacturing locations across India and exports to more than 50 countries. Nuwal and his brother Kailashchandra, also a billionaire, have been embroiled in a feud since 2020. Here in this article, we have listed the names of four corporate leaders who surprised everyone 1. Murali Divi (74): Founder & MD, Divi's Laboratories From an American scientist to a successful pharmaceutical entrepreneur Net worth: ₹95,734 crore All About Murali Divi: Divi's Laboratories is known for its expertise in Active Pharmaceutical Ingredients (APIs) Murali Divi is renowned for his journey from being a scientist in the US to becoming a successful entrepreneur. Instead of chasing profits, he has focused on innovation, high quality, and sustainable growth in business. 2. Vikram Lal (83): 96% Market Share in 500-800cc Bike Segment Founder, Eicher Motors Net worth: ₹87,186 crore All About Vikram Lal Eicher Motors is widely recognized for Royal Enfield. The company holds a 96% market share in the 500-800cc motorcycle segment. It also has a joint venture with Volvo for trucks and buses. The company has preserved the legacy of one of the oldest motorcycle brands. 3. Benu Bangur (94): Delivered Triple the Returns of Sensex This Year Chairman Emeritus, Shree Cement Net worth: ₹72,655 crore All About Benu Bangur Shree Cement sells cement under brands like Ultra Jung Rodhak, Bangur Cement, and Rockstrong. Honorary chairman Benu Bangur belongs to a prominent business family from Kolkata. The company is among the most cost-efficient cement producers in India. 4. Satyanarayan Nuwal (72): Over 40% Returns in the Past Three Years Co-founder and Chairman, Solar Industries Net worth: ₹67,527 crore
Business Upturn
02-07-2025
- Business
- Business Upturn
Stocks hitting 52-week highs today, July 2: Divi's Laboratories, Bharti Airtel, UltraTech Cement, Dalmia Bharat and more
By Aman Shukla Published on July 2, 2025, 15:45 IST Despite broader market weakness on July 2, several stocks managed to hit their 52-week highs, signalling strong investor interest. The Sensex slipped 287.60 points to close at 83,409.69, while the Nifty ended 88.40 points lower at 25,453.40. However, the following stocks stood out by touching fresh 52-week highs during the session. Key Stocks That Hit 52-Week Highs Today (July 2) Company Market Price (₹) 52-Week High (₹) Divi's Laboratories 6,859.50 (+0.04%) 6,885.50 Bharti Airtel 2,033.30 (+0.69%) 2,045.80 Laurus Labs 756.75 (+1.43%) 761.75 UltraTech Cement 12,436.00 (+1.85%) 12,527.00 SRF 3,255.60 (+1.74%) 3,281.60 JK Lakshmi Cement 986.00 (+3.56%) 995.00 Federal Bank 217.75 (-0.44%) 220.00 LT Foods 494.75 (+3.95%) 500.00 Dalmia Bharat 2,220.10 (+1.43%) 2,245.00 Ramco Cements 1,088.40 (+1.04%) 1,101.90 Asahi India Glass 830.55 (+3.01%) 842.00 L&T Finance 206.22 (-0.78%) 209.60 AU Small Finance Bank 818.25 (-2.40%) 841.00 KRBL 379.50 (+1.12%) 390.40 Gabriel India 976.20 (+15.84%) 1,011.30 Cholamandalam Financial Holdings 2,148.80 (+1.74%) 2,231.60 South Indian Bank 31.04 (-1.77%) 32.25 Fiem Industries 1,923.30 (-0.77%) 1,999.00 City Union Bank 221.44 (-3.93%) 232.55 Sai Life Sciences 789.10 (+1.19%) 838.50 Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information. Ahmedabad Plane Crash Bharti AirtelDalmia BharatDivi's LaboratoriesStock MarketUltraTech Cement Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
Business Upturn
18-06-2025
- Business
- Business Upturn
Divi's Laboratories shares in focus after Novartis and MSN settle on Entresto 659 patent
Shares of Divi's Laboratories are in focus after an update in the legal proceedings surrounding Novartis' heart failure drug Entresto. Novartis and MSN Laboratories have reached a settlement on the '659 patent, which was one of the key patents protecting Entresto. With this settlement, attention now shifts to the next patent in the litigation timeline. The subsequent patent is set to expire in November 2026, with associated regulatory exclusivity extending until May 2027. According to analysts, this development could lead to potential upward revisions in Divi's financial estimates for FY26 and FY27, depending on how the litigation progresses and market dynamics evolve in the coming quarters. Divi's Laboratories shares traded in a narrow range today, opening at ₹6,548 and, at the time of writing, reached an intraday high of ₹6,640.50. The stock touched a low of ₹6,513 during the session. It remains close to its 52-week high of ₹6,862.50, while the 52-week low stands at ₹4,395.30. Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
